Hair loss is not an unserved market, but it’s not a well-served one. The available drugs are older products initially developed for other indications and they don’t address hair loss’s underlying ...
LOS ANGELES, Aug. 13, 2024 /PRNewswire/ -- Pelage Pharmaceuticals, a clinical-stage regenerative medicine company pioneering a new generation of treatments for hair loss, today announced that the ...
Pelage Pharmaceuticals has raised nearly $17 million in a series A funding round to develop a small-molecule treatment for alopecia and other types of hair loss. The Los Angeles–based biotechnology ...
Company expands board of directors and makes key leadership promotions to support upcoming late-stage trials of PP405 in androgenetic alopeciaMaykin Ho, Ph.D., appointed to Pelage board of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results